[1] 胡蓉,周立娟.硼替佐米联合地塞米松与沙利度胺对多发性骨髓瘤伴肾功能不全患者骨代谢调节因子、免疫功能及肾功能的影响[J].海南医学院学报,2017,23(22):3092-3095. [2] 施玲玲,李翰卿,梅建刚,等.硼替佐米和沙利度胺治疗对多发性骨髓瘤患者外周血记忆性T细胞亚群和调节性T细胞的影响及临床意义[J].中国实验血液学杂志,2018,36(2):225-225. [3] 童春,郭智,楼金星,等.DVD方案治疗复发难治性多发性骨髓瘤效果的初步观察[J].肿瘤研究与临床,2016,28(9):620-623. [4] 魏振军,张宏艳,谭晓华,等.脂质体多柔比星加强的DVD方案治疗多发性骨髓瘤效果观察[J].肿瘤研究与临床,2017,29(9):607-610. [5] 徐颖洁,黄红铭,徐瑞容.多发性骨髓瘤患者乙型肝炎病毒流行情况及相关预后分析[J].临床内科杂志,2017,34(9):622-624. [6] 邹昭玲,王小华,陶盛能,等.CTD方案与TD方案对初治多发性骨髓瘤的疗效对比[J].实用癌症杂志,2017,32(4):668-670. [7] 王敏敏,颜敏超,郭晓珺.硼替佐米和沙利度胺治疗多发性骨髓瘤致相关周围神经病变机制[J].诊断学理论与实践,2016,15(6):629-631. [8] Wang J , Udd K A , Vidisheva A ,et al. Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.[J]. Supportive Care in Cancer Official J the Multinational Association of Supportive Care in Cancer, 2016, 24(7):3105-3110.
2019, Vol. 36 
